Literature DB >> 10482702

Lymph node micrometastases in patients with adenocarcinoma of the esophagogastric junction.

L Bonavina1, S Ferrero, V Midolo, R Buffa, B Cesana, A Peracchia.   

Abstract

Recurrences of adenocarcinoma of the esophagogastric junction are frequent even in patients who are classified as pN0 after radical resection, suggesting that occult nodal metastases may have been missed on routine histologic examination. Immunohistochemical analysis using antibodies to cytokeratin was retrospectively performed in 1301 lymph nodes from 46 patients who underwent surgical resection for adenocarcinoma of the esophagogastric junction through a laparotomy and a right thoracotomy. Compared to routinely stained sections, the total number of metastatic lymph nodes was significantly (P = 0.0001) increased when both serial sectioning and anticytokeratin immunohistochemical analysis were performed. Overall 6 (33.3%) of the 18 patients previously considered N0 were recategorized as N1 for the presence of micrometastases to lesser curvature nodes. Three of these patients had recurrent disease within the first year of follow-up. Both the probability of survival or no recurrence and the disease-free survival were significantly greater in patients in whom the ratio of invaded to removed lymph nodes was less than 0.2. Anticytokeratin analysis identified occult nodal metastases in one third of our patients with adenocarcinoma of the esophagogastric junction. This modified tumor staging and had an impact on overall and disease-free survival.

Entities:  

Mesh:

Year:  1999        PMID: 10482702     DOI: 10.1016/s1091-255x(99)80099-7

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  17 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

2.  Esophagogastrectomy for adenocarcinoma of the cardia. Ten years' experience and current approach.

Authors:  J E Molina; B R Lawton; W O Myers; E W Humphrey
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

3.  Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases.

Authors:  J R Siewert; R Kestlmeier; R Busch; K Böttcher; J D Roder; J Müller; C Fellbaum; H Höfler
Journal:  Br J Surg       Date:  1996-08       Impact factor: 6.939

4.  Cardia carcinoma considered as a distinct clinical entity.

Authors:  B Husemann
Journal:  Br J Surg       Date:  1989-02       Impact factor: 6.939

5.  Adenocarcinoma of the cardia: the choice of surgical treatment.

Authors:  A Peracchia; R Bardini; L Bonavina; M Asolati; B Martella; A Ruol; M Rossi
Journal:  Ital J Surg Sci       Date:  1987

6.  Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence.

Authors:  Y Maehara; T Oshiro; K Endo; H Baba; S Oda; Y Ichiyoshi; S Kohnoe; K Sugimachi
Journal:  Surgery       Date:  1996-04       Impact factor: 3.982

7.  Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia.

Authors:  J A Hagen; J H Peters; T R DeMeester
Journal:  J Thorac Cardiovasc Surg       Date:  1993-11       Impact factor: 5.209

8.  Lymph node metastasis in patients with adenocarcinoma of gastric cardia.

Authors:  L S Wang; C W Wu; M J Hsieh; H J Fahn; M H Huang; K Y Chien
Journal:  Cancer       Date:  1993-03-15       Impact factor: 6.860

9.  Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification.

Authors:  W H Steup; P De Leyn; G Deneffe; D Van Raemdonck; W Coosemans; T Lerut
Journal:  J Thorac Cardiovasc Surg       Date:  1996-01       Impact factor: 5.209

Review 10.  Improved axillary staging of breast cancer with sentinel lymphadenectomy.

Authors:  A E Giuliano; P S Dale; R R Turner; D L Morton; S W Evans; D L Krasne
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

View more
  10 in total

1.  Feasibility study of sentinel lymph node biopsy in esophageal cancer with conservative lymphadenectomy.

Authors:  Sarah K Thompson; Dylan Bartholomeusz; Peter G Devitt; Peter J Lamb; Andrew R Ruszkiewicz; Glyn G Jamieson
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

Review 2.  [Minimal residual tumor in gastrointestinal carcinoma. Relevance to prognosis and oncologic surgical consequences].

Authors:  S Gretschel; A Bembenek; T Schulze; W Kemmner; P M Schlag
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

3.  Isolated tumour cells in pathological node-negative lymph nodes adversely affect prognosis in cancer of the oesophagus or oesophagogastric junction.

Authors:  Martin J MacGuill; Ciara Barrett; Narayanasamy Ravi; George MacDonald; John V Reynolds
Journal:  J Clin Pathol       Date:  2007-01-12       Impact factor: 3.411

4.  Histopathological assessment of lymph nodes in upper gastrointestinal cancer: does triple levelling detect significantly more metastases?

Authors:  Stephen McGrath; Sarah Cross; Susan Anne Pritchard
Journal:  J Clin Pathol       Date:  2007-02-13       Impact factor: 3.411

5.  Results of surgical therapy in patients with Barrett's adenocarcinoma.

Authors:  Luigi Bonavina; Albert Via; Raffaello Incarbone; Greta Saino; Alberto Peracchia
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

6.  Occult disseminated tumor cells in lymph nodes of patients with gastric carcinoma. A critical appraisal of assessment and relevance.

Authors:  Peter Scheunemann; Nikolas H Stoecklein; Kai Hermann; Alexander Rehders; Claus F Eisenberger; Wolfram T Knoefel; Stefan B Hosch
Journal:  Langenbecks Arch Surg       Date:  2008-07-15       Impact factor: 3.445

7.  Frequency and prognostic significance of occult tumor cells in lymph nodes in patients with adenocarcinoma of the papilla of Vater.

Authors:  P Scheunemann; N H Stoecklein; A Rehders; M Bidde; S Metz; M Peiper; C Eisenberger; J Schulte Am Esch; W T Knoefel; S B Hosch
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

8.  Occult tumor cells in lymph nodes as a predictor for tumor relapse in pancreatic adenocarcinoma.

Authors:  Peter Scheunemann; Nikolas H Stoecklein; Alexander Rehders; Minu Bidde; Sylvia Metz; Matthias Peiper; Claus F Eisenberger; Jan Schulte Am Esch; Wolfram T Knoefel; Stefan B Hosch
Journal:  Langenbecks Arch Surg       Date:  2007-08-18       Impact factor: 3.445

9.  Lymph Node Micrometastases are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma.

Authors:  Hendrik T J Mantel; Jim K Wiggers; Joanne Verheij; Jan J Doff; Egbert Sieders; Thomas M van Gulik; Annette S H Gouw; Robert J Porte
Journal:  Ann Surg Oncol       Date:  2015-07-16       Impact factor: 5.344

10.  New evidence guiding extent of lymphadenectomy for esophagogastric junction tumor: Application of Ber-Ep4 Joint with CD44v6 staining on the detection of lower mediastinal lymph node micrometastasis and survival analysis.

Authors:  Bin Zheng; Chen-Hui Ni; Hao Chen; Wei-Dong Wu; Zhao-Hui Guo; Yong Zhu; Wei Zheng; Chun Chen
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.